Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 117
Filter
1.
Scand J Rheumatol ; 50(6): 479-484, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34132168

ABSTRACT

Objectives: Objective outcome measures of systemic sclerosis (SSc)-related Raynaud's phenomenon (RP) are badly needed. Our objectives were to validate the thermographic response to a standard hand cold challenge as an outcome measure by assessing sensitivity to change, and to explore mobile phone thermography as a feasible, ambulatory tool.Method: Twelve patients with an SSc-spectrum disorder admitted for intravenous iloprost infusions underwent a standard cold challenge before and after one infusion. Thermographic measurements included area under the rewarming curve (AUC) and maximum rewarming temperature (MAX). Before and during another infusion, each patient underwent monitoring of finger skin temperature by two methods: continuous thermocouple recording (standard method) and mobile phone thermography.Results: All cold challenge summary measures, including AUC and MAX, increased after iloprost (most not significantly). However, when the response curves were modelled after averaging across fingers (linear mixed models, three versions), significant change was detected. For example, with Model 1 (no interaction between period and time), temperature was on average 1.67ºC [95% confidence interval (CI) 1.49-1.85, p < 0.001] higher post-iloprost. Mobile phone and thermocouple temperature measurements showed a strong estimated latent correlation (0.88, 95% CI 0.81-0.92). The estimated increases/hour were 0.25ºC (95% CI 0.05-0.45) for the thermocouple and 0.36ºC (95% CI 0.13-0.60) for mobile phone thermography.Conclusion: Our pilot study suggests that the thermographic response to a cold challenge is sensitive to change and mobile phone thermography could bring feasibility to thermographic parameters as outcome measures in later-phase, large-scale, community-based clinical trials of RP.


Subject(s)
Raynaud Disease , Scleroderma, Systemic , Thermography , Cell Phone , Cold Temperature , Humans , Iloprost , Outcome Assessment, Health Care , Pilot Projects , Raynaud Disease/diagnosis , Scleroderma, Systemic/complications , Scleroderma, Systemic/therapy
2.
Int J Obes (Lond) ; 43(9): 1724-1734, 2019 09.
Article in English | MEDLINE | ID: mdl-30349011

ABSTRACT

BACKGROUND AND OBJECTIVES: Matrix metalloproteinases (MMPs) are involved in several inflammatory processes including obesity-related vascular diseases and graft failure of coronary artery (CA) bypass grafts [internal mammary artery (IMA), saphenous vein (SV)]. In these inflammatory conditions, the release of prostaglandin E2 (PGE2) is increased via the activity of inducible microsomal PGE synthase-1 (mPGES-1). Our aim was to investigate whether MMPs and their endogenous inhibitor (TIMPs) may be regulated by PGE2 under inflammatory conditions in human vasculature and perivascular adipose tissue (PVAT), as well as in plasma of obese patients. METHODS: MMP-1,-2 and TIMP-1,-2 densities were measured in human plasma (n = 68) as well as in supernatants of human vascular wall (IMA n = 16, SV n = 14, CA n = 13) and their PVAT. The effects of inflammation and mPGES-1 inhibitor (Compound III, 10 µM) on MMPs regulation were evaluated. The correlations between PGE2 and several parameters were calculated in plasma from patients with or without obesity. RESULTS: The vascular wall and PVAT from SV exhibited the greatest MMP-1,-2 release. An increase of MMP-1,-2 and/or a decrease of TIMP-1 quantities have been detected under inflammation only in vascular wall not in PVAT. These changes under inflammation were completely reversed by inhibition of mPGES-1. In obesity, C-reactive protein (CRP), biomarker of inflammation, and PGE2 levels were increased. PGE2 contents were positively correlated with some anthropometric parameters and plasmatic CRP in both genders, while the correlation with the plasmatic MMP-1 density was significant only in women. CONCLUSIONS: The greater MMP activity observed in SV may contribute to the increased prevalence of graft failure. Under inflammation, the greater mPGES-1 and PGE2 levels lead to enhanced MMP activity in human vascular walls. The positive association between PGE2 and MMP-1 or CRP has been observed in plasma of women. We suggest that mPGES-1 inhibitors could prevent graft failure and obesity-related vascular remodeling mostly in women.


Subject(s)
Dinoprostone/metabolism , Inflammation/metabolism , Mammary Arteries/metabolism , Matrix Metalloproteinases/metabolism , Obesity/metabolism , Aged , Dinoprostone/analysis , Dinoprostone/blood , Female , Humans , Male , Mammary Arteries/chemistry , Matrix Metalloproteinases/analysis , Matrix Metalloproteinases/blood , Middle Aged
3.
Lupus ; 26(10): 1023-1033, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28134039

ABSTRACT

Objective The objective of this study was to investigate the association of clinical and renal disease activity with circulating sphingolipids in patients with systemic lupus erythematosus. Methods We used liquid chromatography tandem mass spectrometry to measure the levels of 27 sphingolipids in plasma from 107 female systemic lupus erythematosus patients and 23 controls selected using a design of experiment approach. We investigated the associations between sphingolipids and two disease activity indices, the Systemic Lupus Activity Measurement and the Systemic Lupus Erythematosus Disease Activity Index. Damage was scored according to the Systemic Lupus International Collaborating Clinics damage index. Renal activity was evaluated with the British Island Lupus Activity Group index. The effects of immunosuppressive treatment on sphingolipid levels were evaluated before and after treatment in 22 female systemic lupus erythematosus patients with active disease. Results Circulating sphingolipids from the ceramide and hexosylceramide families were increased, and sphingoid bases were decreased, in systemic lupus erythematosus patients compared to controls. The ratio of C16:0-ceramide to sphingosine-1-phosphate was the best discriminator between patients and controls, with an area under the receiver-operating curve of 0.77. The C16:0-ceramide to sphingosine-1-phosphate ratio was associated with ongoing disease activity according to the Systemic Lupus Activity Measurement and the Systemic Lupus Erythematosus Disease Activity Index, but not with accumulated damage according to the Systemic Lupus International Collaborating Clinics Damage Index. Levels of C16:0- and C24:1-hexosylceramides were able to discriminate patients with current versus inactive/no renal involvement. All dysregulated sphingolipids were normalized after immunosuppressive treatment. Conclusion We provide evidence that sphingolipids are dysregulated in systemic lupus erythematosus and associated with disease activity. This study demonstrates the utility of simultaneously targeting multiple components of a pathway to establish disease associations.


Subject(s)
Immunosuppressive Agents/therapeutic use , Lupus Erythematosus, Systemic/blood , Sphingolipids/blood , Adult , Case-Control Studies , Chromatography, Liquid/methods , Cross-Sectional Studies , Female , Humans , Lupus Erythematosus, Systemic/drug therapy , Lupus Erythematosus, Systemic/physiopathology , Middle Aged , Severity of Illness Index , Tandem Mass Spectrometry/methods
5.
Heart Lung ; 43(4): 351-7, 2014.
Article in English | MEDLINE | ID: mdl-24856227

ABSTRACT

OBJECTIVES: To describe a multidimensional symptom profile in patients with stable chronic obstructive pulmonary disease (COPD) and determine whether symptom experience differed between patients with moderate or severe airflow limitations. BACKGROUND: Patients with severe airflow limitation experience numerous symptoms, but little is known regarding patients with moderate airflow limitation. METHODS: A multidimensional symptom profile (Memorial Symptom Assessment Scale) was assessed in 42 outpatients with moderate and 49 with severe airflow limitations. RESULTS: The mean number of symptoms in the total sample was 7.9 (±4.3) with no difference between patients with moderate and severe airflow limitations. The most prevalent symptoms with the highest MSAS symptom burden scores were shortness of breath, dry mouth, cough, sleep problems, and lack of energy in both groups. CONCLUSIONS: Patients with moderate or severe airflow limitations experience multiple symptoms with high severity and distress. An assessment of their multidimensional symptom profile might contribute to better symptom management.


Subject(s)
Pulmonary Disease, Chronic Obstructive/complications , Aged , Cost of Illness , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulmonary Disease, Chronic Obstructive/psychology
6.
Scand J Immunol ; 77(5): 350-60, 2013 May.
Article in English | MEDLINE | ID: mdl-23488692

ABSTRACT

PGE2 is a potent lipid mediator of pain and oedema found elevated in RA. Microsomal prostaglandin E synthase-1 (mPGES-1) is a terminal enzyme of the PGE2 pathway inducible by proinflammatory cytokines. mPGES-1 is markedly upregulated in RA synovial tissue despite antirheumatic treatments, suggesting that multiple inflammatory stimuli contribute to its induction. High-mobility group box chromosomal protein 1 (HMGB1) is known to induce inflammation both by direct interaction with TLR4 and by enhancement of other proinflammatory molecules signalling, through complex formation. The high expression of extracellular HMGB1 within the inflamed synovium, implies its pro-arthritogenic role in RA. We aimed to investigate the effects of IL-1ß/HMGB1 complexes on mPGES-1 and other enzymes of the PGE2 pathway in synovial fibroblasts (SFs) from patients with arthritis. Furthermore, we studied the effect of COX-2 inhibition and IL-1RI antagonism on prostanoid and cytokine production by SFs. Stimulation of SFs with HMGB1 in complex with suboptimal amounts of IL-1ß significantly increased mPGES-1 and COX-2 expressions as well as PGE2 production, as compared to treatment with HMGB1 or IL-1ß alone. Furthermore, NS-398 reduced the production of IL-6 and IL-8, thus indicating that IL-1ß/HMGB1 complexes modulate cytokine production in part through prostanoid synthesis. Treatment with IL-1RA completely abolished the induced PGE2 and cytokine production, suggesting an effect mediated through IL-1RI. IL-1ß/HMGB1 complexes promote the induction of mPGES-1, COX-2 and PGE2 in SF. The amplification of the PGE2 biosynthesis pathway by HMGB1 might constitute an important pathogenic mechanism perpetuating inflammatory and destructive activities in rheumatoid arthritis.


Subject(s)
Biosynthetic Pathways/drug effects , Dinoprostone/biosynthesis , Fibroblasts/drug effects , HMGB1 Protein/pharmacology , Interleukin-1beta/pharmacology , Interleukin-8/metabolism , Arthritis/metabolism , Arthritis/pathology , Blotting, Western , Cells, Cultured , Chemokines/metabolism , Cyclooxygenase 2/metabolism , Cyclooxygenase Inhibitors/pharmacology , Cytokines/metabolism , Drug Synergism , Fibroblasts/metabolism , Humans , Interleukin 1 Receptor Antagonist Protein/pharmacology , Interleukin-6/metabolism , Intramolecular Oxidoreductases/metabolism , Nitrobenzenes/pharmacology , Prostaglandin-E Synthases , Sulfonamides/pharmacology , Synovial Membrane/metabolism , Synovial Membrane/pathology
7.
Science ; 333(6039): 199-202, 2011 Jul 08.
Article in English | MEDLINE | ID: mdl-21680811

ABSTRACT

Variable x-ray and γ-ray emission is characteristic of the most extreme physical processes in the universe. We present multiwavelength observations of a unique γ-ray-selected transient detected by the Swift satellite, accompanied by bright emission across the electromagnetic spectrum, and whose properties are unlike any previously observed source. We pinpoint the event to the center of a small, star-forming galaxy at redshift z = 0.3534. Its high-energy emission has lasted much longer than any γ-ray burst, whereas its peak luminosity was ∼100 times higher than bright active galactic nuclei. The association of the outburst with the center of its host galaxy suggests that this phenomenon has its origin in a rare mechanism involving the massive black hole in the nucleus of that galaxy.

8.
Nature ; 461(7268): 1254-7, 2009 Oct 29.
Article in English | MEDLINE | ID: mdl-19865165

ABSTRACT

Long-duration gamma-ray bursts (GRBs) are thought to result from the explosions of certain massive stars, and some are bright enough that they should be observable out to redshifts of z > 20 using current technology. Hitherto, the highest redshift measured for any object was z = 6.96, for a Lyman-alpha emitting galaxy. Here we report that GRB 090423 lies at a redshift of z approximately 8.2, implying that massive stars were being produced and dying as GRBs approximately 630 Myr after the Big Bang. The burst also pinpoints the location of its host galaxy.

9.
Ann Rheum Dis ; 67(11): 1596-602, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18094001

ABSTRACT

OBJECTIVES: To investigate the expression of microsomal prostaglandin E (PGE) synthase 1 (mPGES-1) and cyclooxygenase (COX) in muscle biopsies from patients with polymyositis or dermatomyositis before and after conventional immunosuppressive treatment. METHODS: mPGES-1 and COX expression was evaluated by immunohistochemistry in muscle tissue from healthy individuals and from patients with polymyositis or dermatomyositis before and after conventional immunosuppressive treatment. The number of inflammatory cell infiltrates, T lymphocytes and macrophages was estimated before and after treatment. To localise the mPGES-1 expression double immunofluorescence was performed with antibodies against mPGES-1, CD3, CD68, CD163 and a fibroblast marker. A functional index was used to assess muscle function. RESULTS: In patients with myositis, mPGES-1, COX-2 and COX-1 expression was significantly higher compared to healthy individuals and associated with inflammatory cells. Double immunofluorescence demonstrated a predominant expression of mPGES-1 in macrophages. Conventional immunosuppressive treatment resulted in improved but still lower muscle function than normal. A decreased number of CD68-positive macrophages and reduced COX-2 expression in muscle tissue was also seen. By contrast, following the same treatment no significant changes were observed in muscle tissue regarding number of infiltrates, T lymphocytes, CD163-positive macrophages or mPGES-1 protein levels. CONCLUSIONS: Increased expression of mPGES-1, COX-1 and COX-2 at protein level was observed in muscle tissue from patients with myositis compared to healthy individuals. Conventional immunosuppressive treatment led to a significant downregulation of COX-2 in myositis muscle tissue. However, the expression of mPGES-1 and COX-1 remained unchanged indicating a role of these enzymes in the chronicity of these diseases.


Subject(s)
Immunosuppressive Agents/therapeutic use , Intramolecular Oxidoreductases/metabolism , Polymyositis/drug therapy , Prostaglandin-Endoperoxide Synthases/metabolism , Adult , Aged , Aged, 80 and over , Biopsy , Cohort Studies , Dermatomyositis/drug therapy , Dermatomyositis/enzymology , Dermatomyositis/pathology , Dermatomyositis/physiopathology , Down-Regulation/drug effects , Female , Humans , Immunosuppressive Agents/pharmacology , Male , Microsomes/enzymology , Middle Aged , Muscle, Skeletal/enzymology , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Polymyositis/enzymology , Polymyositis/pathology , Polymyositis/physiopathology , Prednisolone/pharmacology , Prednisolone/therapeutic use , Prostaglandin-E Synthases
10.
Clin Physiol Funct Imaging ; 26(5): 271-4, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16939503

ABSTRACT

Investigations in chronic obstructive pulmonary disease (COPD) patients have shown impaired glucose tolerance in hypoxic COPD patients, compared with COPD patients with normal arterial blood gases. In healthy subjects, hypoxaemia or stay at altitude, have been shown to alter glucose metabolism. At altitude the effect seems to be dependent on duration of stay. A short stay is associated with insulin resistance, a longer stay gives rise to increased glucose uptake. The euglycaemic hyperinsulinaemic glucose clamp technique is a method to study glucose tolerance and enables determinations of glucose clearance in peripheral tissues. We investigated six COPD patients [forced expiratory volume in 1 s 0.7 +/- 0.2 l (mean +/- SD)] with chronic hypoxaemia (PaO(2) 7.9 +/- 0.6 kPa at rest, breathing air), with and without oxygen supplementation, using the glucose clamp technique. Net peripheral glucose uptake was 5.5 +/- 1.2 and 7.1 +/- 1.6 mg (kg*min)(-1) (+29%) breathing air and supplemental oxygen, respectively (P = 0.03). The tissue sensitivity to insulin increased 32% (P = 0.03) with oxygen supplementation. The results indicate that normalization of oxygen saturation in COPD patients with chronic hypoxaemia may have an immediate effect on glucose tolerance and tissue sensitivity to insulin in these patients.


Subject(s)
Glucose Clamp Technique/methods , Glucose/metabolism , Hypoxia/therapy , Oxygen Inhalation Therapy , Oxygen/therapeutic use , Pulmonary Disease, Chronic Obstructive/therapy , Aged , Female , Glucose Intolerance/therapy , Humans , Insulin/metabolism , Male , Middle Aged , Oxygen/metabolism , Time Factors
11.
Acta Ophthalmol Scand ; 83(1): 76-80, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15715562

ABSTRACT

PURPOSE: The aim of this prospective study was to compare visual screening at the age of 3 years with screening at 4 years using two different charts. METHODS: A total of 478 3-year-old children were tested at four child health care centres (CHCCs). Of these children, 440 were tested again at the age of 4 years. A third group, a control group, consisting of 229 children, was examined only at the age of 4 years. All children were tested with both the HVOT chart and the Lea Symbol chart. RESULTS: Testability rates for 3-year-olds were almost the same with the Lea Symbol chart and the HVOT chart (82.8% and 84.8%, respectively). The corresponding rates for the same children tested at 4 years of age were 96.5% and 97.0%, and for the 4-year-olds not previously tested 92.9% and 92.8%. The mean testing time was somewhat shorter for the Lea Symbol chart in all three groups, but the difference was not statistically significant. The difference in the assessment of visual acuity between the two charts was small and less than 1/10th of a line. The positive predictive value was lower at 3 years (58%) than has previously been found at 4 years (74.6%). CONCLUSION: Three-year-old children co-operate well in visual acuity testing. However, the examination time is a little longer and the testability rate is about 10% lower than at 4 years. Both 3-year-old and 4-year-old children can be tested equally well with the HVOT and the Lea Symbol charts.


Subject(s)
Amblyopia/diagnosis , Vision Screening/instrumentation , Visual Acuity , Child, Preschool , False Positive Reactions , Feasibility Studies , Female , Humans , Male , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Vision Screening/methods
12.
Cell Mol Life Sci ; 62(1): 87-94, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15619010

ABSTRACT

Cysteinyl-leukotrienes (cys-LTs) are potent smooth muscle contracting agents, which play key roles in inflammatory and allergic diseases. The committed step in cys-LT biosynthesis is catalyzed by leukotriene C(4) synthase (LTC4S) as well as microsomal glutathione S-transferase type 2 (MGST2) and type 3 (MGST3). Here we report that intraperitoneal injections of lipopolysaccharide in rats lead to a strong increase of LTC4S messenger RNA (mRNA) levels after approximately 1 h, particularly in the heart, brain, adrenal glands and liver, without any significant effect on MGST2 and MGST3 mRNA levels. After 6 h, LTC4S mRNA returns to basal levels, concomitant with a 4.9-, 4.0-, 2.9- and 2.3-fold induction of LTC4S protein in brain, heart, liver and adrenal gland, respectively. Hence, challenge with lipopolysaccharide in vivo causes an organ-selective, local priming for leukotriene C(4) synthesis. Moreover, these data suggest that LTC4S and cys-LTs may be involved in acute systemic inflammatory responses such as fever and tachycardia.


Subject(s)
Fever/enzymology , Glutathione Transferase/biosynthesis , Up-Regulation , Animals , Brain/metabolism , Brain Chemistry , Cysteine/metabolism , Fever/chemically induced , Fever/genetics , Glutathione Transferase/analysis , Glutathione Transferase/genetics , Inflammation/genetics , Inflammation/metabolism , Leukotrienes/metabolism , Lipopolysaccharides , Male , Microsomes/enzymology , RNA, Messenger/analysis , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Tissue Distribution
13.
Arthritis Rheum ; 50(6): 1774-80, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15188353

ABSTRACT

OBJECTIVE: Microsomal prostaglandin E synthase 1 (mPGES-1) catalyzes the formation of PGE(2) from cyclooxygenase-derived PGH(2). Microsomal PGES-1 is induced by proinflammatory cytokines and is strongly linked to conditions that result in high PGE(2) biosynthesis. PGE(2) contributes to the pathogenesis of rheumatoid arthritis (RA), acting as a mediator of inflammation and promoting bone destruction. Induction of mPGES-1 in rheumatoid synoviocytes by proinflammatory cytokines has been demonstrated in vitro, indicating an important role in RA pathogenesis. Recent studies using mPGES-1-deficient mice demonstrated the importance of this gene in chronic inflammation. The aim of this study was to investigate the expression and localization of mPGES-1 in synovial biopsy specimens obtained from patients with RA. METHODS: Synovial tissue samples from 24 patients with RA were obtained, and immunohistologic analysis was performed using polyclonal antibodies against mPGES-1. Double immunofluorescence staining was performed with antibodies to CD3, CD19, CD20, CD68, CD163, and prolyl 4-hydroxylase. RESULTS: Intracellular mPGES-1 staining was observed in synovial membranes from all of the RA patients studied. Specifically, strong expression of mPGES-1 was detected in synovial lining cells. In sublining mononuclear and fibroblast-like cells, the extent of mPGES-1 staining was less than that in the synovial lining cells. In some patients, positive staining was observed in endothelial cells. With the double immunofluorescence technique, mPGES-1 production was detected in synovial macrophages and fibroblasts, while mPGES-1 expression was not observed in lymphocytes. CONCLUSION: The demonstration of mPGES-1 expression in synovial tissues from patients with RA suggests a role for mPGES-1 in the RA disease process. Microsomal PGES-1 might be a potential new target for treatment strategies to control PGE(2) synthesis in patients with RA, without the systemic side effects associated with cyclooxygenase inhibitors.


Subject(s)
Arthritis, Rheumatoid/metabolism , Intramolecular Oxidoreductases/metabolism , Synovial Membrane/enzymology , Antibody Specificity , Arthritis, Rheumatoid/pathology , Dinoprostone/metabolism , Fluorescent Antibody Technique , Humans , Intramolecular Oxidoreductases/immunology , Microsomes/enzymology , Prostaglandin-E Synthases , Synovial Membrane/pathology
14.
Acta Paediatr ; 92(12): 1468-73, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14971800

ABSTRACT

AIM: To evaluate the efficacy of two different Swedish screening procedures for early detection of congenital cataracts in comparison with no screening. METHODS: Children born between January 1992 and December 1998 in Swedish regions with an established eye-screening routine procedure, diagnosed with congenital cataract, and operated on before 1 y of age, were included in a retrospective study. Age at referral and age at time of the operation were compared between regions using different screening procedures: screening in the maternity wards (Region 1), at the well-baby clinics (Region 2) and one region without any screening (Region 3). RESULTS: Seventy-two children were included in the study. Concerning early diagnosis and surgery, Region 1 differed significantly from Regions 2 and 3, which were more similar and were combined for further analysis. The difference in detected cases was greatest at 21 d of age (55% vs 18%; p < 0.001), but persisted even at 100 d of age (78% vs 64%; p < 0.02). Region 1 screening resulted in more and earlier cases detected than the other two regions (22 vs 15 per 100,000 births). In 72% of all cases, surgery was performed in response to referrals from either the maternity wards (36%), or the well-baby clinics (36%). However, half of the cases from the well-baby clinics were detected too late, i.e. at > 100 d. CONCLUSION: Eye screening in the maternity ward is preferable to well-baby clinic screening and to no screening at all, since it leads to early detection. Screening should also be performed routinely at well-baby clinics within the period when successful treatment is possible.


Subject(s)
Cataract/congenital , Cataract/diagnosis , Neonatal Screening/methods , Humans , Infant , Infant, Newborn , Retrospective Studies
15.
Neuroscience ; 115(3): 891-7, 2002.
Article in English | MEDLINE | ID: mdl-12435427

ABSTRACT

Microsomal glutathione S-transferase type 3 (MGST3) is a recently identified member of a large superfamily of enzymes involved in biotransformation of xenobiotics and biosynthesis of eicosanoids, including prostaglandins and leukotrienes. Using in situ hybridization histochemistry and reverse transcription polymerase chain reaction, we characterized the expression of MGST3 mRNA in the rat nervous system based on the cloned rat MGST3 gene, under normal conditions and after systemic administration of lipopolysaccharide (LPS). The MGST3 mRNA seemed to be confined to neurons. The broad distribution in the brain was characterized by a strong signal in the hippocampal formation and in the nuclei of the cranial nerves. A moderate signal was found in the cortex, thalamus, amygdala and substantia nigra and a weak signal in the hypothalamus. Motoneurons in the spinal cord and sensory neurons in dorsal root ganglia displayed strong MGST3 mRNA signal. No significant changes in the level of expression of MGST3 mRNA in the brain were found 1, 3 or 6 h after LPS administration. The pattern of distribution of MGST3 mRNA in the rat nervous system and the lack of response to LPS do not support a role for MGST3 in the biosynthesis of proinflammatory eicosanoids but rather suggest other functions, perhaps in metabolic detoxication and neuroprotection.


Subject(s)
Gene Expression Regulation, Enzymologic/genetics , Glutathione Transferase/genetics , Microsomes/enzymology , Nervous System/enzymology , Neurons/enzymology , Animals , Brain/cytology , Brain/enzymology , Ganglia, Spinal/cytology , Ganglia, Spinal/enzymology , Inflammation/genetics , Inflammation/metabolism , Lipopolysaccharides , Male , Nervous System/cytology , Neurons/cytology , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects , Reaction Time/genetics , Spinal Cord/cytology , Spinal Cord/enzymology
16.
Clin Cancer Res ; 7(12): 3971-6, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11751489

ABSTRACT

Recently, an inducible microsomal human prostaglandin E synthase (mPGES) was identified. This enzyme converts the cyclooxygenase (COX) product prostaglandin (PG) H(2) to PGE(2), an eicosanoid that has been linked to carcinogenesis. Increased amounts of PGE(2) have been observed in many tumor types including colorectal adenomas and cancers. To further elucidate the mechanism responsible for increased levels of PGE(2) in colorectal tumors, we determined the amounts of mPGES and COX-2 in 18 paired samples (tumor and adjacent normal) of colorectal cancer. With immunoblot analysis, mPGES was overexpressed in 83% of colorectal cancers. COX-2 was also commonly up-regulated in these tumors; marked differences in the extent of up-regulation of mPGES and COX-2 were observed in individual tumors. Immunohistochemistry revealed increased mPGES immunoreactivity in neoplastic cells in both colorectal adenomas and cancers compared with adjacent normal colonic epithelium. Cell culture was used to investigate the regulation of mPGES and COX-2. Chenodeoxycholate markedly induced COX-2 but not mPGES in colorectal cancer cells. Tumor necrosis factor-alpha induced both mPGES and COX-2, but the time course and magnitude of induction differed. As reported previously for COX-2, overexpressing Ras caused a several-fold increase in mPGES promoter activity. Taken together, our results suggest that overexpression of mPGES in addition to COX-2 contributes to increased amounts of PGE(2) in colorectal adenomas and cancer. The mechanisms controlling the expression of these two enzymes are not identical.


Subject(s)
Adenoma/enzymology , Colorectal Neoplasms/enzymology , Intramolecular Oxidoreductases/biosynthesis , Adenocarcinoma , Blotting, Western , Cell Line , Chenodeoxycholic Acid/pharmacology , Colonic Neoplasms , Colorectal Neoplasms/pathology , Colorectal Neoplasms/surgery , Cyclooxygenase 2 , Dinoprostone/metabolism , Enzyme Induction , Gene Expression Regulation, Enzymologic , Humans , Intestinal Mucosa/enzymology , Intestinal Mucosa/pathology , Intramolecular Oxidoreductases/genetics , Isoenzymes/genetics , Isoenzymes/metabolism , Membrane Proteins , Prostaglandin-E Synthases , Prostaglandin-Endoperoxide Synthases/genetics , Prostaglandin-Endoperoxide Synthases/metabolism , Recombinant Proteins/biosynthesis , Transfection , Tumor Necrosis Factor-alpha/pharmacology
17.
Clin Cancer Res ; 7(9): 2669-74, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11555578

ABSTRACT

An inducible microsomal form of human prostaglandin E synthase (mPGES) was recently identified. This enzyme converts the cyclooxygenase (COX) product, prostaglandin (PG) H2, to PGE2, a prostanoid that has been implicated in carcinogenesis. Increased amounts of PGE2 are detected in many types of cancer, but the underlying mechanism is not fully understood. Hence, we compared amounts of mPGES in 19 paired samples (tumor and adjacent normal tissue) of non-small cell lung cancer (NSCLC). By immunoblot analysis, mPGES was overexpressed in about 80% of NSCLCs. Immunohistochemistry localized the expression of mPGES to neoplastic epithelial cells. COX-2 was also commonly up-regulated in these tumors; marked differences in the extent of up-regulation of mPGES and COX-2 were observed in individual tumors. Cell culture was used to define the underlying mechanism(s) that accounts for up-regulation of mPGES in NSCLC. As reported previously for COX-2, levels of mPGES mRNA and protein were increased in NSCLC cell lines containing mutant Ras as compared with a nontumorigenic bronchial epithelial cell line. Nuclear run-offs revealed increased rates of mPGES transcription in the transformed cell lines. Overexpression of Ras caused a severalfold increase in mPGES promoter activity in nontransformed cells. Tumor necrosis factor-alpha induced mPGES and COX-2 in NSCLC cell lines but had no effect on the expression of either enzyme in a nontumorigenic bronchial epithelial cell line. Consistent with prior observations for COX-2, these data suggest that both cellular transformation and cytokines contribute to the up-regulation of mPGES in NSCLC.


Subject(s)
Carcinoma, Non-Small-Cell Lung/pathology , Intramolecular Oxidoreductases/genetics , Lung Neoplasms/pathology , Carcinoma, Non-Small-Cell Lung/enzymology , Carcinoma, Non-Small-Cell Lung/genetics , Cyclooxygenase 2 , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , Immunoblotting , Intramolecular Oxidoreductases/drug effects , Intramolecular Oxidoreductases/metabolism , Isoenzymes/drug effects , Isoenzymes/metabolism , Lung Neoplasms/enzymology , Lung Neoplasms/genetics , Membrane Proteins , Prostaglandin-E Synthases , Prostaglandin-Endoperoxide Synthases/drug effects , Prostaglandin-Endoperoxide Synthases/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/pharmacology
18.
Acta Ophthalmol Scand ; 79(3): 240-4, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11401631

ABSTRACT

PURPOSE: This study describes the various ophthalmological conditions detected in the Swedish visual screening program for children. METHODS: The study was longitudinal and retrospective. All children (3126) born in 1982 in three Swedish municipalities have been followed from birth to ten years of age. Visual acuity was examined at the ages of 4, 5.5, 7 and 10 years. Before the age of 4, a gross examination of the eyes was performed. RESULTS: The prevalence of ametropia in the population was 7.7%, the prevalence of strabismus 3.1%, and the prevalence of organic lesions 0.6%. Seven children (0.2%) were visually handicapped (visual acuity

Subject(s)
Amblyopia/epidemiology , Refractive Errors/epidemiology , Strabismus/epidemiology , Vision Screening , Age Distribution , Amblyopia/diagnosis , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Male , Prevalence , Refraction, Ocular , Refractive Errors/diagnosis , Retrospective Studies , Strabismus/diagnosis , Sweden/epidemiology , Visual Acuity
19.
J Immunol ; 167(1): 469-74, 2001 Jul 01.
Article in English | MEDLINE | ID: mdl-11418684

ABSTRACT

The selective induction of PGE(2) synthesis in inflammation suggests that a PGE synthase may be linked to an inducible pathway for PG synthesis. We examined the expression of the recently cloned inducible microsomal PGE synthase (mPGES) in synoviocytes from patients with rheumatoid arthritis, its modulation by cytokines and dexamethasone, and its linkage to the inducible cyclooxygenase-2. Northern blot analysis showed that IL-1beta or TNF-alpha treatment induces mPGES mRNA from very low levels at baseline to maximum levels at 24 h. IL-1beta-induced mPGES mRNA was inhibited by dexamethasone in a dose-dependent fashion. Western blot analysis demonstrated that mPGES protein was induced by IL-1beta, and maximum expression was sustained for up to 72 h. There was a coordinated up-regulation of cyclooxygenase-2 protein, although peak expression was earlier. Differential Western blot analysis of the microsomal and the cytosolic fractions revealed that the induced expression of mPGES protein was limited to the microsomal fraction. The detected mPGES protein was catalytically functional as indicated by a 3-fold increase of PGES activity in synoviocytes following treatment with IL-1beta; this increased synthase activity was limited to the microsomal fraction. In summary, these data demonstrate an induction of mPGES in rheumatoid synoviocytes by proinflammatory cytokines. This novel pathway may be a target for therapeutic intervention for patients with arthritis.


Subject(s)
Arthritis, Rheumatoid/enzymology , Cytokines/physiology , Glucocorticoids/physiology , Inflammation Mediators/physiology , Intramolecular Oxidoreductases/metabolism , Microsomes/enzymology , Synovial Membrane/enzymology , Synovial Membrane/immunology , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/metabolism , Cells, Cultured , Cyclooxygenase 2 , Cytosol/enzymology , Dexamethasone/pharmacology , Dinoprostone/biosynthesis , Enzyme Activation/immunology , Enzyme Induction/genetics , Enzyme Induction/immunology , Humans , Interleukin-1/physiology , Intramolecular Oxidoreductases/biosynthesis , Intramolecular Oxidoreductases/genetics , Isoenzymes/biosynthesis , Isoenzymes/genetics , Isoenzymes/metabolism , Membrane Proteins , Prostaglandin-E Synthases , Prostaglandin-Endoperoxide Synthases/biosynthesis , Prostaglandin-Endoperoxide Synthases/genetics , RNA, Messenger/biosynthesis , Synovial Membrane/metabolism , Synovial Membrane/pathology
20.
Eur J Biochem ; 268(9): 2578-86, 2001 May.
Article in English | MEDLINE | ID: mdl-11322876

ABSTRACT

Certain immunocompetent myeloid cells, such as eosinophils, basophils and mast cells, have a large capacity to synthesize the potent proinflammatory and spasmogenic mediator leukotriene (LT) C4 via a specific microsomal glutathione S-transferase (MGST) termed LTC4 synthase (LTC4S). Here, we report that MGST2, a distant homologue of LTC4S, is abundantly expressed in Human umbilical vein endothelial cells (HUVEC) and converts LTA4 into a single product, LTC4. Thus, using Northern blot, RT-PCR, Western blot, and enzyme activity assays, we show that MGST2 is the main, if not the only, enzyme that converts LTA4 into LTC4 in membrane preparations of HUVEC. In fact, we failed to detect any expression of LTC4S, MGST1 or MGST3 in these cells, indicating that MGST2 is a critical enzyme for transcellular LTC4 biosynthesis in the vascular wall. Unlike LTC4S, MGST2 prefers the naturally occurring free acid of LTA4 over the methyl ester as substrate and is also susceptible to product inhibition with an IC50 of about 1 microM for LTC4. Moreover, HUVEC were found to express the CysLT1 receptor in line with a paracrine and autocrine role for cysteinyl-leukotrienes in endothelial cell function.


Subject(s)
Endothelium, Vascular/metabolism , Glutathione Transferase/metabolism , Leukotriene C4/biosynthesis , Membrane Proteins , Receptors, Leukotriene/metabolism , Blotting, Northern , Blotting, Western , Cells, Cultured , Enzyme Inhibitors/pharmacology , Glutathione Transferase/antagonists & inhibitors , Glutathione Transferase/genetics , Humans , Leukotriene A4/metabolism , Leukotriene C4/pharmacology , Microsomes/enzymology , Models, Biological , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Leukotriene/genetics , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Substrate Specificity , Umbilical Veins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...